Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-1271
Clinical Microbiology Market is poised to value USD 6402.13 million by 2028 end at a CAGR of 6.5% during the forecast period 2022 to 2028. Increasing air pollution levels with rapid industrialization is leading into an expeditious escalation in occurrences of respiratory diseases. Furthermore, amongst all kinds of infections, respiratory diseases are transmitted rapidly as the contagious pathogens are easily passed on from one person to another. Therefore, this segment is predicted to showcase substantial augmentation during the forecast period. Moreover, rising incidences of infectious diseases in developing as well as developed countries which is another factor contributing to the segment growth. Additionally, as per a few observations that were published in the Journal of the American Medical Association (AMA), persistent respiratory diseases were the reason for over 1 in every 20 deaths in 2015. In 2013, around USD 130 billion of healthcare expenditures were related to these diseases. Blood tests, bronchoscopy and biopsy are commonly utilized tools for diagnosing respiratory diseases. Thus, increasing incidences of persistent respiratory diseases is an integral factor stimulating the global clinical microbiology market growth. The market is segmented on the basis of end users as academic and research institutes, custom lab service providers and hospitals and diagnostic centres. The custom lab service providers are predicted to showcase the highest proliferation over the forecast period due to the drug testing processes that are continuously outsources to laboratory services by pharmaceutical companies, benefits provided by the procedures of advanced molecular technology-based instruments like NGS and PCR in discovering drugs, rising number of clinical trials based on microbiology and the increasing number of service providers of custom labs across key market regions. Key market players included in the global clinical microbiology industry are Biomerieux, Danaher Corp., Becton, Dickinson and Co., Abbott, Roche Diagnostics, Bruker, Hologic, Bio-Rad, Qiagen, Thermo Fisher Scientific, Agilent, Merck KGaA, Shimadzu, 3M, Neogen. Clinical Microbiology Market Segmentation: By Application Pharmaceutical Applications Food Testing Applications Clinical Applications Energy Applications Chemical & Material Manufacturing Applications Environmental Applications By Product • Instruments o Laboratory Instruments • Incubators • Gram Stainers • Bacterial Colony Counters • Autoclave Sterilizers • Microbial Air Samplers • Anaerobic Culture Systems • Petri Dish Fillers • Blood Culture Systems • Microbial Culture Systems • Other Laboratory Instruments o Microbiology Analyzers • Molecular Diagnostic Instruments • Microscopes • Mass Spectrometers • Reagents o Pathogen-Specific Kits o General Reagents By Indication Respiratory Diseases Bloodstream Infections Gastrointestinal Diseases Sexually Transmitted Diseases Urinary Tract Infections Periodontal Diseases Other Indications By End User Hospitals & Diagnostic Centres Custom Lab Service Providers Academic & Research Institutes By Region North America Europe Asia Pacific Latin America Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global clinical microbiology market by application, by product, by indication, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increasing air pollution levels with rapid industrialization is leading into an expeditious escalation in occurrences of respiratory diseases. Furthermore, amongst all kinds of infections, respiratory diseases are transmitted rapidly as the contagious pathogens are easily passed on from one person to another. Therefore, this segment is predicted to showcase substantial augmentation during the forecast period. Moreover, rising incidences of infectious diseases in developing as well as developed countries which is another factor contributing to the segment growth.
Additionally, as per a few observations that were published in the Journal of the American Medical Association (AMA), persistent respiratory diseases were the reason for over 1 in every 20 deaths in 2015. In 2013, around USD 130 billion of healthcare expenditures were related to these diseases. Blood tests, bronchoscopy and biopsy are commonly utilized tools for diagnosing respiratory diseases. Thus, increasing incidences of persistent respiratory diseases is an integral factor stimulating the global clinical microbiology market growth.
The market is segmented on the basis of end users as academic and research institutes, custom lab service providers and hospitals and diagnostic centres. The custom lab service providers are predicted to showcase the highest proliferation over the forecast period due to the drug testing processes that are continuously outsources to laboratory services by pharmaceutical companies, benefits provided by the procedures of advanced molecular technology-based instruments like NGS and PCR in discovering drugs, rising number of clinical trials based on microbiology and the increasing number of service providers of custom labs across key market regions.
Key market players included in the global clinical microbiology industry are Biomerieux, Danaher Corp., Becton, Dickinson and Co., Abbott, Roche Diagnostics, Bruker, Hologic, Bio-Rad, Qiagen, Thermo Fisher Scientific, Agilent, Merck KGaA, Shimadzu, 3M, Neogen.
Clinical Microbiology Market Segmentation:
By Application
By Product
• Instruments o Laboratory Instruments • Incubators • Gram Stainers • Bacterial Colony Counters • Autoclave Sterilizers • Microbial Air Samplers • Anaerobic Culture Systems • Petri Dish Fillers • Blood Culture Systems • Microbial Culture Systems • Other Laboratory Instruments o Microbiology Analyzers • Molecular Diagnostic Instruments • Microscopes • Mass Spectrometers • Reagents o Pathogen-Specific Kits o General Reagents
By Indication
By End User
By Region
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Clinical Microbiology Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Clinical Microbiology Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Clinical Microbiology Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Clinical Microbiology Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Instruments 7.1.1. Laboratory Instruments 7.1.1.1. Incubators 7.1.1.2. Gram Stainers 7.1.1.3. Bacterial Colony Counters 7.1.1.4. Autoclave Sterilizers 7.1.1.5. Microbial Air Samplers 7.1.1.6. Anaerobic Culture Systems 7.1.1.7. Petri Dish Fillers 7.1.1.8. Blood Culture Systems 7.1.1.9. Microbial Culture Systems 7.1.1.10. Other Laboratory Instruments 7.1.2. Microbiology Analyzers 7.1.2.1. Molecular Diagnostic Instruments 7.1.2.2. Microscopes 7.1.2.3. Mass Spectrometers 7.2. Reagents 7.2.1. Pathogen-Specific Kits 7.2.2. General Reagents 8. Clinical Microbiology Market, By Indication Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Respiratory Diseases 8.2. Bloodstream Infections 8.3. Gastrointestinal Diseases 8.4. Sexually Transmitted Diseases 8.5. Urinary Tract Infections 8.6. Periodontal Diseases 8.7. Other Indications 9. Clinical Microbiology Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Pharmaceutical Applications 9.2. Food Testing Applications 9.3. Clinical Applications 9.4. Energy Applications 9.5. Chemical & Material Manufacturing Applications 9.6. Environmental Applications 10. Clinical Microbiology Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospitals & Diagnostic Centres 10.2. Custom Lab Service Providers 10.3. Academic & Research Institutes 11. North America Clinical Microbiology Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Clinical Microbiology Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Clinical Microbiology Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Clinical Microbiology Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Biomérieux 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Danaher Corporation 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Becton, Dickinson and Company 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Abbott 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.) 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Bruker 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Hologic 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Bio-Rad 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Qiagen 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Thermo Fisher Scientific 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Agilent 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.Merck KGaA 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Shimadzu 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.3M 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15.Neogen 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Clinical Microbiology Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Clinical Microbiology Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Clinical Microbiology Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Clinical Microbiology Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Instruments 7.1.1. Laboratory Instruments 7.1.1.1. Incubators 7.1.1.2. Gram Stainers 7.1.1.3. Bacterial Colony Counters 7.1.1.4. Autoclave Sterilizers 7.1.1.5. Microbial Air Samplers 7.1.1.6. Anaerobic Culture Systems 7.1.1.7. Petri Dish Fillers 7.1.1.8. Blood Culture Systems 7.1.1.9. Microbial Culture Systems 7.1.1.10. Other Laboratory Instruments 7.1.2. Microbiology Analyzers 7.1.2.1. Molecular Diagnostic Instruments 7.1.2.2. Microscopes 7.1.2.3. Mass Spectrometers 7.2. Reagents 7.2.1. Pathogen-Specific Kits 7.2.2. General Reagents
8. Clinical Microbiology Market, By Indication Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Respiratory Diseases 8.2. Bloodstream Infections 8.3. Gastrointestinal Diseases 8.4. Sexually Transmitted Diseases 8.5. Urinary Tract Infections 8.6. Periodontal Diseases 8.7. Other Indications
9. Clinical Microbiology Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Pharmaceutical Applications 9.2. Food Testing Applications 9.3. Clinical Applications 9.4. Energy Applications 9.5. Chemical & Material Manufacturing Applications 9.6. Environmental Applications
10. Clinical Microbiology Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospitals & Diagnostic Centres 10.2. Custom Lab Service Providers 10.3. Academic & Research Institutes
11. North America Clinical Microbiology Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Clinical Microbiology Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Clinical Microbiology Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Clinical Microbiology Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Biomérieux 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Danaher Corporation 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Becton, Dickinson and Company 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Abbott 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.) 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Bruker 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Hologic 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Bio-Rad 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Qiagen 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Thermo Fisher Scientific 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Agilent 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.Merck KGaA 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 17.13.Shimadzu 17.13.1. Company Overview 17.13.2. Product Portfolio 17.13.3. SWOT Analysis 17.13.4. Financial Overview 17.13.5. Strategic Overview 17.14.3M 17.14.1. Company Overview 17.14.2. Product Portfolio 17.14.3. SWOT Analysis 17.14.4. Financial Overview 17.14.5. Strategic Overview 17.15.Neogen 17.15.1. Company Overview 17.15.2. Product Portfolio 17.15.3. SWOT Analysis 17.15.4. Financial Overview 17.15.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics